PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) WITH NEPA, THE FIRST ORAL COMBINATION ANTIEMETIC, IN PATIENTS WITH GYNECOLOGICAL CANCERS RECEIVING PLATINUM-BASED CHEMOTHERAPY

被引：0
|
作者：
Bosnjak, S. [1 ]
Stamatovic, L. [1 ]
Jordan, K. [2 ]
Rizzi, G. [3 ]
机构：
[1] Inst Oncol & Radiol Serbia, Med Oncol, Belgrade, Serbia
[2] Univ Halle Wittenberg, Oncol Hematol, D-06108 Halle, Germany
[3] Helsinn Healthcare, Biostat, Lugano, Switzerland
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2015年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ESGO-0356
引用
收藏
页码：582 / 583
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy
    Bosnjak, Snezana M.
    Stamatovic, Ljiljana
    Borroni, Maria Elisa
    Rizzi, Giada
    Jordan, Karin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (06) : 1153 - 1161
  • [2] Analysis of Quality-of-Life (QoL) in Patients Receiving NEPA for Prevention of Chemotherapy-Induced Nausea (CINV) and Vomiting
    Karthaus, Meinolf
    Zahn, M. O.
    Tschechne, B.
    Gerber, B.
    Haas, S.
    Schwindel, U.
    Konias, M.
    Rotmann, A. R.
    Schilling, J.
    BLOOD, 2020, 136
  • [3] Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Baron-Hay, Sally
    Aapro, Matti
    Bernareggi, Alberto
    Schwartzberg, Lee
    SUPPORTIVE CARE IN CANCER, 2019, 27 (04) : 1309 - 1317
  • [4] Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Sally Baron-Hay
    Matti Aapro
    Alberto Bernareggi
    Lee Schwartzberg
    Supportive Care in Cancer, 2019, 27 : 1309 - 1317
  • [5] Combination Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients with NSCLC Receiving Carboplatin-Based Chemotherapy
    Shimokawa, Mototsugu
    Haratake, Naoki
    Takada, Kazuki
    Toyokawa, Gouji
    Takamori, Shinkichi
    Mizuki, Fumitaka
    Takenaka, Tomoyoshi
    Hayashi, Toshinobu
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2673 - 2680
  • [6] Netupitant/palonosetron (NEPA) for prevention of delayed chemotherapy-induced nausea and vomiting (CINV) in multiple cycles of chemotherapy.
    Schwartzberg, Lee Steven
    Gralla, Richard J.
    Kashef, Kimia
    Rugo, Hope
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [7] Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers
    Navari, R.
    Jordan, K.
    Rapoport, B. L.
    Schnadig, I.
    Chasen, M.
    Arora, S.
    Powers, D.
    Schwartzberg, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Preventing chemotherapy-induced nausea and vomiting in patients with lung cancer: efficacy of NEPA (netupitant-palonosetron), the first combination antiemetic
    Hesketh, Paul J.
    Palmas, Marco
    Nicolas, Pierre
    SUPPORTIVE CARE IN CANCER, 2018, 26 (04) : 1151 - 1159
  • [9] Preventing chemotherapy-induced nausea and vomiting in patients with lung cancer: efficacy of NEPA (netupitant-palonosetron), the first combination antiemetic
    Paul J. Hesketh
    Marco Palmas
    Pierre Nicolas
    Supportive Care in Cancer, 2018, 26 : 1151 - 1159
  • [10] Prolonged usage of fosaprepitant for prevention of delayed chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly emetogenic chemotherapy
    Gao, Ai
    Guan, Shasha
    Sun, Yinjuan
    Wang, Lingling
    Meng, Fanlu
    Liu, Xia
    Gu, Liyan
    Li, Guo
    Zhong, Diansheng
    Zhang, Linlin
    BMC CANCER, 2023, 23 (01)
12345